Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India's biotech and biomaterials gain EU plaudits:

This article was originally published in Clinica

Executive Summary

India's biotechnology and biomaterials sectors are among those most suited to co-operation between the EU and India, "given the state-of-the-art of science" in the two regions, suggests a European Commission background paper. Though known as the "third world research superpower", India is still underdeveloped, it says. Despite this, the country's biomaterial sciences are featured for their "high-level of expertise", while the National Institute of Immunology and the International Centre for Genetic Engineering and Biotechnology are described as world class institutions. Biotechnology is not currently a priority of its E2.5 billion ($2.2 billion, 0.72% of GDP) R&D budget, 17% of which is provided by industry.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel